Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma.

Ying LiWenbin JiangTianhao LiMengyue LiXin LiZheyang ZhangSainan ZhangYixin LiuWenyuan ZhaoYunyan GuLishuang QiLu AoZheng Guo

Published in: Journal of translational medicine (2020)

The small-CDS mutation panel of only 0.34 Mb is superior to current commercial mutation panels and can better predict the efficacy of immunotherapy for LUAD patients, and its low cost and time-intensiveness make it more suitable for clinical applications.

Keyphrases

low cost
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
quantum dots
prognostic factors